RT journal article
T1 Development and Effectiveness of a Mobile Health Intervention in Improving Health Literacy and Self-management of Patients With Multimorbidity and Heart Failure: Protocol for a Randomized Controlled Trial
A1 Bas Sarmiento, María del Pilar
A1 Fernández Gutiérrez, Martina
A1 Poza Méndez, Miriam
A1 Marín Paz, Antonio Jesús
A1 Paloma Castro, Olga
A1 Romero Sánchez, José Manuel
A1 ASyAG_PPIC Team
A2 Enfermería y Fisioterapia
K1 Health Literacy
K1 mHealth
K1 RCT
K1 Self-Management
K1 Multimorbidity
K1 Heart Failure
K1 Randomized Controlled Trial
K1 Mobile App
AB - Background: Patients with multimorbidity and complex health needs are defined as a priority by the World Health Organization (WHO) and the European Union. There is a need to develop appropriate strategies with effective measures to meet the challenge of chronicity, reorienting national health systems. The increasing expansion of mobile health (mHealth) interventions in patient communication, the reduction of health inequalities, improved access to health care resources, adherence to treatment, and self-care of chronic diseases all point to an optimistic outlook. However, only few mobile apps demonstrate their effectiveness in these patients, which is diminished when they are not based on evidence, or when they are not designed by and for users with different levels of health literacy (HL).- Objective: This study aims to evaluate the efficacy of an mHealth intervention relative to routine clinical practice in improving HL and self-management in patients with multimorbidity with heart failure (HF) and complex health needs.- Methods: This is a randomized, multicenter, blinded clinical trial evaluating 2 groups, namely, a control group (standard clinical practice) and an intervention group (standard clinical practice and an ad hoc designed mHealth intervention previously developed), for 12 months.- Results: The contents of the mHealth intervention will address user-perceived needs based on the development of user stories regarding diet, physical exercise, cardiac rehabilitation, therapeutic adherence, warning signs and symptoms, and emotional management. These contents have been validated by expert consensus. The creation and development of the contents of the mHealth intervention (app) took 18 months and was completed during 2021. The mobile app is expected to be developed by the end of 2022, after which it will be applied to the experimental group as an adjunct to standard clinical care during 12 months.- Conclusions: The trial will demonstrate whether the mobile app improves HL and self-management in patients with HF and complex health needs, improves therapeutic adherence, and reduces hospital admissions. This study can serve as a starting point for developing other mHealth tools in other pathologies and for their generalization to other contexts.
SN 1929-0748
YR 2022
FD 2022-04-29
LK http://hdl.handle.net/10498/26963
UL http://hdl.handle.net/10498/26963
LA eng
NO Trial Registration: ClinicalTrials.gov NCT04725526
DS Repositorio Institucional de la Universidad de Cádiz
RD 21-sep-2026